Richman, Lee P.
Abramson Cancer Center · University of Pennsylvania
3 papers on CoChatORCID 0000-0002-4601-5190
Most cited papers
- Verified
Antifibrotic effects of the dual CCR2/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis
Lefebvre, E., Moyle, G., Reshef, R., Richman, L. P., Thompson, M., Hong, F., Chou, H.-L., Hashiguchi, T., Plato, C., Poulin, D., et al. (2016) · PLOS ONE
Liver physiology and pathologyChemokine receptors and signaling
Cited by 323
- Verified
Human Treg responses allow sustained recombinant adeno-associated virus–mediated transgene expression
Mueller, C., Chulay, J. D., Trapnell, B. C., Humphries, M., Carey, B., Sandhaus, R. A., McElvaney, N. G., Messina, L., Tang, Q., Rouhani, F. N., et al. (2013) · Journal of Clinical Investigation
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 169
- Verified
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
Bear, A. S., Blanchard, T., Cesare, J., Ford, M. J., Richman, L. P., Xu, C., Baroja, M. L., McCuaig, S., Costeas, C., Gabunia, K., et al. (2021) · Nature Communications
Immunotherapy and Immune Responsesvaccines and immunoinformatics approaches
Cited by 113
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free